On September 9, 2024, Novo Nordisk A/S reported it started a share repurchase program on August 7, 2024, aiming to buy back B shares worth up to DKK 20 billion over 12 months. As of September 6, 2024, they have repurchased 12,023,313 B shares at an average price of DKK 880.98, totaling approximately DKK 10.6 billion.